tirzepatide journal club – IM Iowa Journal Club | Tirzepatide in

Some patients report difficulty obtaining specific doses, potentially affecting pricing and availability

intra-articular injection dosing for joint conditions is determined by the administering physician Frequency Once daily, or divided into two doses for higher-dose subcutaneous protocols Administration Subcutaneous injection near the injury site (musculoskeletal and systemic)

Tirzepatide# Tirzepatide is a 39-amino acid dual GIP/GLP-1 receptor agonist with approximately 5-fold potency at GIPR relative to native GIP and 0.2-fold at GLP-1R relative to native GLP-1

PeterMD provides compounded tirzepatide, not brand-name Zepbound or Mounjaro